📰 Beigene News
Page 9 - Beigene News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Beigene. Real-time updates on events, politics, business and more.
May 30, 2023
BeiGene’s BTKi is approved in more than 65 markets globally ... | May 30, 2023
May 25, 2023
Highlights from early- and late-stage pipeline include -- combination data for cornerstone therapies BRUKINSA and tislelizumab -- early results for OX40 agonist BGB-A445 and BCL-2 inhibitor... | May 25, 2023
May 24, 2023
BeiGene , a global biotechnology company, today announced that the Company will participate in fireside chats at two upcoming investor conferences: TD Cowen 4th Annual Oncology Innovation Summit... | May 24, 2023
May 22, 2023
StockNews.com assumed coverage on shares of BeiGene (NASDAQ:BGNE – Get Rating) in a research report report published on Thursday morning. The brokerage issued a hold rating on the stock. Several other equities research analysts have also weighed in on BGNE. Cowen lifted their price target on BeiGene from $213.00 to $262.00 and gave the company […]
May 21, 2023
StockNews.com assumed coverage on shares of BeiGene (NASDAQ:BGNE – Get Rating) in a report published on Thursday. The firm issued a hold rating on the stock. Several other brokerages have also issued reports on BGNE. Guggenheim reiterated a buy rating and issued a $350.00 price target on shares of BeiGene in a research note on […]
May 19, 2023
StockNews.com assumed coverage on shares of BeiGene (NASDAQ:BGNE – Get Rating) in a research note released on Thursday. The brokerage issued a hold rating on the stock. Other analysts also recently issued reports about the company. SVB Leerink upped their target price on BeiGene from $236.00 to $300.00 and gave the company an outperform rating […]
May 18, 2023
Prudential PLC lessened its position in shares of BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) by 45.9% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,616 shares of the company’s stock after selling 2,223 shares during the quarter. Prudential PLC’s holdings in BeiGene were […]
May 17, 2023
The Max Foundation (Max), a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients worldwide, BeiGene, a global
May 17, 2023
The Max Foundation , a global nonprofit organization dedicated to accelerating health equity by delivering medication, technology, and supportive services to patients worldwide, BeiGene, a global... | May 17, 2023
May 11, 2023
XY Capital Ltd bought a new position in BeiGene, Ltd. (NASDAQ:BGNE – Get Rating) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 5,018 shares of the company’s stock, valued at approximately $1,104,000. BeiGene comprises about 0.7% of XY Capital Ltd’s holdings, making the stock its 23rd […]